"In Arkansas, for example, we now have half the urologists that there were 25 years ago, and that's with an increasing population. That's a representation of what's going on across the country," says R. Jonathan Henderson, MD.
In this interview, R. Jonathan Henderson, MD, discusses some of the biggest challenges that urologists face in group practice, including staffing shortages and legislative regualtions, which can contribute to the high burnout rates seen among urologists. Henderson was interviewed at the 2022 LUGPA Annual Meeting in Chicago, Illinois. He is currently a practicing urologist at Arkansas Urology.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.